Navigation Links
Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com
Date:5/27/2015

Dallas, TX (PRWEB) May 27, 2015

The report “Premature Ejaculation – Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Premature Ejaculation. Premature ejaculation is when a man has an orgasm sooner during intercourse. Premature ejaculation is a common problem among men. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H1 2015 pipeline review of Premature Ejaculation with 23 market data tables and 14 figures, spread across 58 pages is available at http://www.rnrmarketresearch.com/premature-ejaculation-pipeline-review-h1-2015-market-report.html .

Companies discussed in this Premature Ejaculation – Pipeline Review, H1 2015 report include Actavis plc, Dong-A Socio Group, NeuroHealing Pharmaceuticals Inc., Plethora Solutions Holdings plc, SK Chemicals Co., Ltd., Yungjin Pharm Ind. Co., Ltd.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are (lidocaine + prilocaine), DA-8031, IX-01, modafinil, NCE-405, onabotulinumtoxin A, tramadol hydrochloride, YPE-1706.

Featured News & Press Releases cover by this report includes: Jan 08, 2015: Vyrix Pharmaceuticals to Present at Biotech Showcase 2015; Nov 11, 2014: Plethora Solutions Provides Company Update; Oct 07, 2014: PSD502 To Be Marketed As Fortacin Throughout The EU; Mar 26, 2014: Plethora Solutions Announces Manufacturing Appointment; Mar 11, 2014: Plethora Solutions Provides Company update; Nov 19, 2013: Plethora Solutions Receives European Commission Approval For PSD502 To Treat Premature Ejaculation; Sep 19, 2013: Plethora Solutions Receives CHMP Positive Opinion For Lidocaine/Prilocaine Plethora For Treatment Of Primary Premature Ejaculation; Jul 01, 2013: AGM Statement & PSD502 Regulatory Update; Jun 03, 2013: Ampio Pharma Provides Update On Sexual Dysfunction Portfolio; Mar 11, 2013: Ampio Receives FDA Acceptance Of Patient Outcome For Premature Ejaculation Questionnaire Paving Way For US Pivotal Trial On Zertane.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=386027 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Premature Ejaculation, H1 2015 7
Number of Products under Development for Premature Ejaculation - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Premature Ejaculation - Pipeline by Actavis plc, H1 2015 14
Premature Ejaculation - Pipeline by Dong-A Socio Group, H1 2015 15
Premature Ejaculation - Pipeline by NeuroHealing Pharmaceuticals Inc., H1 2015 16
Premature Ejaculation - Pipeline by Plethora Solutions Holdings plc, H1 2015 17
Premature Ejaculation - Pipeline by SK Chemicals Co., Ltd., H1 2015 18
Premature Ejaculation - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015 19
Assessment by Monotherapy Products, H1 2015 20
Assessment by Combination Products, H1 2015 21
Number of Products by Stage and Target, H1 2015 23
Number of Products by Stage and Mechanism of Action, H1 2015 25
Number of Products by Stage and Route of Administration, H1 2015 27
Number of Products by Stage and Molecule Type, H1 2015 29
Premature Ejaculation Therapeutics - Recent Pipeline Updates, H1 2015 42
Premature Ejaculation - Dormant Projects, H1 2015 48
Premature Ejaculation - Dormant Projects (Contd..1), H1 2015 49
Premature Ejaculation - Discontinued Products, H1 2015 50

List of Figures
Number of Products under Development for Premature Ejaculation, H1 2015 7
Number of Products under Development for Premature Ejaculation - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Top 10 Targets, H1 2015 22
Number of Products by Stage and Top 10 Targets, H1 2015 23
Number of Products by Top 10 Mechanism of Actions, H1 2015 24
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 25
Number of Products by Top 10 Routes of Administration, H1 2015 26
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 27
Number of Products by Top 10 Molecule Types, H1 2015 28
Number of Products by Stage and Top 10 Molecule Types, H1 2015 29

Explore more reports on Men's Health therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/mens-health-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/premature-ejaculation/pipeline-review-h1-2015/prweb12748561.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Baltimore Co. Jury Awards Family $2M in Premature Birth Lawsuit with Help from Birth Injury Attorneys at Gilman & Bedigian LLC
2. Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant
3. Premature Labor (Tocolysis) Therapeutic Pipeline Drugs and Companies Review H1 2015 Research Report Available at RnRMarketResearch.com
4. NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks
5. Premature Births Down in U.S., But Rates Still High, Reports Say
6. PTSD in Women Linked to Premature Birth
7. Gentle caffeine boost for premature babies
8. The viability of premature babies is minimal at 22 weeks gestation
9. A new therapeutic target may prevent blindness in premature babies at risk of retinopathy
10. Scientists map risk of premature menopause after cancer treatment
11. Human milk fat improves growth in premature infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in ... has a lot to offer to the discussion of dealing with excess skin oil. ... there are many home remedies that can help remove the oily shine while keeping the ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... treatment, with or without a referral. Sleep apnea is often left untreated because patients ... morning headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of ...
(Date:3/27/2017)... London UK (PRWEB) , ... March 27, 2017 ... ... agility and ability to gain site attention and engagement over the household brands ... educational webinar will discuss how partnering with the right outsourcing payments ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 The global market ... with the top three companies, namely Shimadzu Corporation, Thermo ... significant 49% of the overall market in 2015, observes ... landscape is intensely competitive and has few players, most ... These factors have restricted the entry of new players ...
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... 28, 2017  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), ... cancer and other unmet medical needs, announced today ... Cancer Research annual meeting.  The first poster to ... "Evaluation of ENMD-2076 in Combination with Anti-PD1 in ... to be presented on April 4 is entitled ...
Breaking Medicine Technology: